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ABSTRACT [300 words] 
Background: Concerns have been raised that the response to the UK COVID-19 pandemic may have worsened 
physical and mental health, and reduced use of health services. However, the scale of the problem is 
unquantified, impeding development of effective mitigations. We asked what has happened to general 
practice contacts for acute physical and mental health outcomes during the pandemic? 
Methods: Using electronic health records from the Clinical Research Practice Datalink (CPRD) Aurum (2017-
2020), we calculated weekly primary care contacts for selected acute physical and mental health conditions 
(including: anxiety, depression, acute alcohol-related events, asthma and chronic obstructive pulmonary 
disease [COPD] exacerbations, cardiovascular and diabetic emergencies). We used interrupted time series 
(ITS) analysis to formally quantify changes in conditions after the introduction of population-wide restrictions 
(‘lockdown’) compared to the period prior to their introduction in March 2020.  
Findings: The overall population included 9,863,903 individuals on 1st January 2017. Primary care contacts for 
all conditions dropped dramatically after introduction of population-wide restrictions. By July 2020, except for 
unstable angina and acute alcohol-related events, contacts for all conditions had not recovered to pre-
lockdown levels. The largest reductions were for contacts for: diabetic emergencies (OR: 0.35, 95% CI: 0.25-
0.50), depression (OR: 0.53, 95% CI: 0.52-0.53), and self-harm (OR: 0.56, 95% CI: 0.54-0.58).  
Interpretation: There were substantial reductions in primary care contacts for acute physical and mental 
conditions with restrictions, with limited recovery by July 2020. It is likely that much of the deficit in care 
represents unmet need, with implications for subsequent morbidity and premature mortality. The conditions 
we studied are sufficiently severe that any unmet need will have substantial ramifications for the people 
experiencing the conditions and healthcare provision. Maintaining access must be a key priority in future 
public health planning (including further restrictions). 
Funding: Wellcome Trust Senior Fellowship (SML), Health Data Research UK. 
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RESULTS IN CONTEXT 
Evidence before this study 
A small study in 47 GP practices in a largely deprived, urban area of the UK (Salford) reported that primary 
care consultations for four broad diagnostic groups (circulatory disease, common mental health problems, 
type 2 diabetes mellitus and malignant cancer) declined by 16-50% between March and May 2020, compared 
to what was expected based on data from January 2010 to March 2020. We searched Medline for other 
relevant evidence of the indirect effect of the COVID-19 pandemic on physical and mental health from 
inception to September 25th 2020, for articles published in English, with titles including the search terms 
(“covid*” or “coronavirus” or “sars-cov-2”), and title or abstracts including the search terms (“indirect impact” 
or “missed diagnos*” or “missing diagnos*” or “delayed diagnos*” or ((“present*” or “consult*” or “engag*” 
or “access*”) AND (“reduction” or “decrease” or “decline”)). We found no further studies investigating the 
change in primary care contacts for specific physical- and mental-health conditions indirectly resulting from 
the COVID-19 pandemic or its control measures. There has been a reduction in hospital admissions and 
presentations to accident and emergency departments in the UK, particularly for myocardial infarctions and 
cerebrovascular accidents. However, there is no published evidence specifically investigating the changes in 
primary care contacts for severe acute physical and mental health conditions. 
Added value of this study 
To our knowledge this is the first study to explore changes in healthcare contacts for acute physical and 
mental health conditions in a large population representative of the UK. We used electronic primary care 
health records of nearly 10 million individuals across the UK to investigate the indirect impact of COVID-19 on 
primary care contacts for mental health, acute alcohol-related events, asthma/chronic obstructive pulmonary 
disease (COPD) exacerbations, and cardiovascular and diabetic emergencies up to July 2020. For all conditions 
studied, we found primary care contacts dropped dramatically following the introduction of population-wide 
restriction measures in March 2020. By July 2020, with the exception of unstable angina and acute alcohol-
related events, primary care contacts for all conditions studied had not recovered to pre-lockdown levels. In 
the general population, estimates of the absolute reduction in the number of primary care contacts up to July 
2020, compared to what we would expect from previous years varied from fewer than 10 contacts per million 
for some cardiovascular outcomes, to 12,800 per million for depression and 6,600 for anxiety. In people with 
COPD, we estimated there were 43,900 per million fewer contacts for COPD exacerbations up to July 2020 
than what we would expect from previous years. 
Implicatins of all the available evidence 
While our results may represent some genuine reduction in disease frequency (e.g. the restriction measures 
may have improved diabetic glycaemic control due to more regular daily routines at home), it is more likely 
the reduced primary care conatcts we saw represent a substantial burden of unmet need (particularly for 
mental health conditions) that may be reflected in subsequent increased mortality and morbidity. Health 
service providers should take steps to prepare for increased demand in the coming months and years due to 
the short and longterm ramifications of reduced access to care for severe acute physical and mental health 
conditions. Maintaining access to primary care is key to future public health planning in relation to the 
pandemic. 
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By October 2020, novel coronavirus disease 2019 (COVID-19) has been diagnosed in more than 40 million 
individuals, with over one million deaths reported worldwide.1 Much research and public health attention has, 
understandably, focused on preventing infections and reducing mortality. However, there are concerning 
reports of decreased health service use.2–5 Inevitably, there will be impacts on non-COVID-19-related 
healthcare provision; healthcare resources have been reallocated to the COVID-19 response and care delivery 
has been modified due to mitigation measures including social distancing.6–11 Additionally, individuals may 
have delayed seeking care (due to fear of infection, or to avoid burdening health services). Psychological 
health will have been affected by pandemic-related fears, employment and financial concerns, and control 
measures (including social distancing, closures of social spaces and isolation),12,13 and lockdown measures are 
likely to have reduced access to mental health care (face-to-face visits and talking therapies). Understanding 
the indirect effects of the pandemic and its control measures is essential for public health planning, 
particularly when/if the COVID-19 pandemic is under control (or if further restrictions are needed), and for 
informing control measures for future pandemics. 
Reports indicate that accident and emergency department attendance and hospital admissions for non-
COVID-related acute concerns in the UK have declined since March 2020.2–4 However, it is not yet clear what 
has happened in primary care across the UK where clinical work has changed rapidly to include more remote 
consultations,14–17 although a regional report indicates reduced primary care consultations.18 
We asked how primary care contacts (including face-to-face or remote consultations, and recording of 
diagnoses from hospital discharge summaries) have changed for selected indirect acute physical and mental 
health effects of the COVID-19 pandemic, to inform decisions on policy responses and resource allocation. 
Although a wide range of diagnoses could be indirectly affected by the COVID-19 pandemic, we focused on 
specific acute conditions that could plausibly be affected including: mental health conditions, acute alcohol-
related events, cardiovascular and diabetic emergencies, and asthma and chronic obstructive pulmonary 
disease (COPD) exacerbations. We specifically selected diabetic and cardiovascular emergencies (including 
myocardial infarction, unstable angina), and asthma/COPD exacerbations, as affected individuals are likely to 
be considered vulnerable (and asked to ‘shield’, i.e. advice for the vulnerable to avoid unnecessary contacts, 
to avoid infection),19 creating a barrier to accessing healthcare resources.   
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We used routinely collected primary care data from electronic health records from general practices 
contributing to Clinical Research Practice Datalink (CPRD) Aurum database (August 2020 build) in the three 
years prior to the COVID-19 pandemic and four months after introducing population-wide restrictions (i.e. 
‘lockdown’) on 23rd March 2020 (1st January 2017- 12th July 2020).20 Code lists for defining all outcomes and 
stratifying variables, and analytic code are available (https://github.com/johntaz/COVID-Collateral). 
Data source 
CPRD Aurum includes de-identified routinely collected primary care health record data from participating 
general practices covering 13% of the UK population, and is broadly representative of the English population 
with respect to age, sex, ethnicity, and geographic region.20 
Study population 
Our overall study population included individuals with at least one year of registration with practices 
contributing to CPRD Aurum (January 2017-July 2020). Included populations (i.e. denominators) varied 
depending on the condition being investigated (Table 1, Figure S1). For example, for diabetic emergencies the 
study population (denominator) only included individuals (aged ≥11 years) with an existing diabetes mellitus 
diagnosis, while for depression, the study included all individuals from the overall study population aged 5 
years and older.  
We followed all individuals from the latest of: study start (1st January 2017), one year from GP registration or, 
for diabetes and respiratory conditions, from meeting our definitions for having diabetes or respiratory 
disease, as appropriate (Table 1). Follow-up ended for all study populations at the earliest of: end of 
registration with GP, death, practice stopped contributing to CPRD, or end of the study period.  
Exposures, outcomes and stratifying variables 
Our exposure was the introduction of population-wide COVID-19 restrictions (i.e. ‘lockdown’ on 23rd March 
2020). As outcomes, we considered the number of weekly primary care contacts for the following conditions 
(separately): mental health (i.e. depression, anxiety, fatal and non-fatal self-harm, severe mental illness, and 
eating and obsessive-compulsive disorders), acute alcohol-related events, diabetic emergencies (e.g. 
ketoacidosis), asthma and COPD exacerbations, and acute cardiovascular (CVD) events (i.e. unstable angina, 
myocardial infarction, transient ischaemic attack, cerebrovascular accident, cardiac failure and venous 
thromboembolisms). We used the term ‘contact’ broadly to represent remote and face-to-face consultations, 
diagnoses from hospital discharge letters, and secondary care referrals. We identified conditions using 
primary care records for diagnoses, symptoms and/or prescribing (Table 1). All outcomes, except 
asthma/COPD exacerbations, were captured based on presence/absence of specific morbidity codes. 
Asthma/COPD exacerbations were based on validated algorithms requiring a combination of specific 
morbidity codes and prescriptions for corticosteroids or, for COPD additionally antibiotics.21,22 For some 
conditions we defined an exclusion period during which we regarded further coding for the same outcome as 
representing the same acute event (e.g. for diabetic emergencies we regarded multiple records within seven 
days of each other as representing the same event). We used different condition-specific time periods to 
define outcome events to account for differences in natural history of study outcomes (Table 1).  
We stratified on the following pre-specified variables: age (in 10-year bands), sex, geographic region, and 
ethnicity. 
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We described all denominator study populations in the first week of January each year (2017-2020). We 
plotted the percentage of our study populations with contacts for particular conditions in given weeks in 2020 
and historical averages for that week (2017-2019). We repeated analyses stratified by age, sex, region, and 
ethnicity.  
To quantify changes in consultation behaviour following introducing restrictions we used an interrupted time 
series (ITS) analysis separating our time series into two periods: 1) Pre-lockdown: 1st January 2017 to March 
1st 2020 for all outcomes except self-harm (which excluded data from 2017 and 2018, Text S1); and 2) With-
restrictions: from 29th March 2020 to the study end (12th July 2020).  
Although restrictions were announced on 23rd March,23 activity levels (measured by mobile phone 
applications and public transport journeys) had declined before the announcement.24–26  To account for 
anticipatory behaviour, we conservatively defined the start of restrictions as the first week of March, and 
removed all data in March up to, and including, the week restrictions were announced from the ITS analysis. 
For our ITS analysis, we used binomial generalised linear models with number of weekly contacts weighted by 
dynamic population sizes (updated weekly).27 We included a linear effect of time to capture long-term 
behaviour trends, a binary pre-lockdown/with-restrictions variable to measure the direct ‘step’ change in 
behaviour, and an interaction between the two to allow for a recovery ‘slope’ change in behaviour. We 
accounted for seasonal effects by including calendar month as a categorical variable, and autocorrelation by 
including first order lagged residuals. Standard errors were scaled to account for overdispersion.27 
To estimate the reduction in contacts as restrictions were introduced (the `step’ change) we reported odds 
ratios (ORs) for the relative difference in contacts at the start of the with-restrictions period compared to the 
end of the pre-lockdown period. To estimate the recovery of contacts over time (the `slope’) we used the 
coefficients from the ITS model to estimate the weekly log odds of contact during the with-restrictions period 
(further details: Text S2).   
To estimate absolute effects of restrictions on the number of contacts, we repeated our analysis using Poisson 
regression to generate linear predictions of the estimated log contact count and the estimated log count if the 
‘restrictions’ term was set to zero (i.e. there had been no restrictions). To quantify absolute changes in 
behaviour over time we compared the point estimate of the estimated number of contacts with and without 
restrictions at two time points: 1 month (26th April) and 3 months after introduction of restrictions (28th June).  
We used Stata version 1628 and R version 4.0.229 for our analyses.  
Sensitivity analyses 
Our definitions for pre-lockdown and with-restrictions periods may have influenced our estimates, so we 
repeated the ITS analysis with the same pre-lockdown period but with variable data-exclusion periods (5 and 7 
weeks, versus 3 weeks in the main analysis) and repeated analyses with the pre-lockdown period ending on 
15th March, the week before restriction introduction,23 excluding data for 0, 3, 5 and 7 weeks as sensitivity 
analyses. Additionally, given the small number of diabetic emergency contacts we varied our definition using 
less specific codes in a post-hoc sensitivity analysis (Text S3).  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted October 30, 2020. ; https://doi.org/10.1101/2020.10.29.20222174doi: medRxiv preprint 
COVID-19 collateral: Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK 




The overall denominator population included 9,863,903 individuals on 1st January 2017 and numbers 
remained relatively stable throughout the study (Table 2). Characteristics of condition-specific study 
populations are in the Appendix (Tables S1-S5).   
Figure 1 shows the percentage of a given study populations with primary care contacts for each condition in 
2020 (red line) and a 3-year historical average for the corresponding week (black line). Across the majority of 
conditions, we observed rapid and sustained decreases in GP contacts between March and July 2020 
compared to pre-lockdown periods. Despite gradual increases in the percentage of contacts following 
restrictions, levels remained below the three-year average for all conditions except acute alcohol-related 
events, which were higher than the historical average in 2020, and unstable angina. During March 2020 we 
observed pronounced increases in contacts related to asthma exacerbations. Patterns were broadly 
consistent when stratified by age (Figure 2), sex, region, and ethnicity (Figures S2-S4).   
There was evidence that contacts for all studied conditions, except acute alcohol-related events, were lower 
after restrictions were announced compared to pre-restriction levels (Figure 3A). The largest relative 
reductions in contact behaviour following restriction introduction were observed for diabetic emergencies 
(OR: 0.35, 95% CI: 0.25-0.50), depression (OR: 0.53, 95% CI: 0.52-0.53), and self-harm (OR: 0.56, 95% CI: 0.54-
0.58) (Figure 3B, Table S6). From March 28th 2020, we saw evidence of increasing contacts for most conditions 
over time. Acute alcohol-related events and unstable angina contacts appeared to recover faster (3-5% 
increase in odds of contact per week) (Figure 3C, Table S7) than, for example, mental health contacts, where 
odds of contact increased by 1-2% per week, despite a 20-40% drop following restrictions (Figure 3B, Table 
S6). Sensitivity analyses varying the choice of restriction period provided broadly consistent results over a 
wide range of scenarios with a notable exception of acute alcohol-related events (Tables S6-S7, Figures S8-
S14).  
Table 3 illustrates the potential impact of reduced contacts on relevant populations. While for some rare 
conditions, the absolute change in contacts was relatively small, other more common conditions had a larger 
absolute change in contacts, for example, in a population of 1 million people with COPD, from the end of 
March to the end of June, we estimated that there were cumulatively 43,900 fewer COPD exacerbation 
contacts per million people with COPD than expected. During the weeks commencing 26th April and 28th June 
we estimated there were 3,640 and 3,230 fewer contacts (per million) than expected respectively, indicating a 
slow return to pre-lockdown contact levels, but not complete recovery. For example, we estimated there 
were cumulatively fewer contacts for: 1) asthma exacerbations (14,100 for every one million people with 
asthma; and 2) depression and anxiety contacts (12,800 and 6,600 respectively) for every one million people 
in the general population (aged ³11 years).   
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Primary care contacts for key physical and mental health conditions dropped dramatically after the 
introduction of population-wide restriction measures in March 2020. By July 2020, with the exception of 
unstable angina and acute alcohol-related contacts, primary care contacts for all conditions studied remained 
below pre-lockdown levels. We estimate that by July 2020, per million people in the general population, there 
were very small (<10) drops in contacts for myocardial infarction, unstable angina and venous 
thromboembolism, but drops of around 6,600 and 12,800 anxiety and depression contacts. Per million people 
with COPD, we estimate 43,900 fewer exacerbation contacts. 
Results in context 
Our study is the first to explore the effect of lockdown measures on primary care contacts for specific acute 
physical and mental health conditions across the UK. A study (47 primary care practices) in a largely deprived 
urban area, badly affected by the pandemic in North West England (Salford) suggested primary care 
consultations across four broad categories (common mental health problems, cardiovascular and 
cerebrovascular disease, type 2 diabetes, and cancer) had reduced by up to 50% by the end of May 2020.18 In 
contrast to the Salford study, our sample was nationally representative and focused on contacts for specific 
disease categories we would expect to present to healthcare providers. Our large sample size allowed us to 
investigate detailed diagnoses (for example, different types of CVD and mental health conditions). 
In September 2020 GPs conducted more face-to-face appointments than any week since March, and more 
consultations overall than prior to the pandemic (43% were telephone appointments).30,31 A study of 51 GP 
practices already offering remote consultations before the pandemic indicated a dip in overall consultations at 
lockdown, but unlike our results for specific acute conditions, their post-lockdown overall consultation 
decrease was less extreme than during Christmas 2019.32 In England there was a 30% decrease in GP 
consultations from the beginning to the end of March 2020,33 with an increase in calls to NHS 111, the non-
urgent telephone helpline. However, over 50% (1,573,835/2,962,751) of these calls went unanswered.34   
Diabetic emergencies 
The reduced diabetic emergency contacts we observed are consistent with the 49% reduction in new type 2 
diabetes contacts (new prescriptions for metformin) in Salford. While the Salford study highlighted missed 
new diagnoses, our study identifies missed contacts for acute deteriorations. Given that 90% of diabetes 
management is in primary care, the large relative reduction in the proportion of people with diabetes with 
diabetic emergency contacts is concerning.35  
Recent evidence indicates a two-way interaction between diabetes and COVID-19, with a potentially causal 
association between COVID-19 infection and dysglycaemia, such that each condition exacerbates the 
other.36,37 Further, there is evidence that other emergency situations impair control of diabetes.38–40 
Consequently, we would expect an increase, rather than decrease, in diabetic emergency contacts. One 
potential explanation for our findings is that individuals experiencing diabetic emergencies may be presenting 
directly to secondary care with delayed recording in the primary care health record. 
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The reduction in CVD contacts is consistent with reports from other UK studies.18,41 Taken alongside findings 
of similar reductions in Emergency Department presentations and hospital admissions for cardiovascular 
outcomes in the UK, our findings highlight an area of major concern,3,42 particularly as evidence from France 
indicates increased out-of-hospital cardiac arrest.43 Severe COVID-19 affects the cardiovascular system;44 
hence, increased primary and secondary care presentations for CVD are expected.45 Indeed, it is possible that 
the more rapid recovery in unstable angina contacts (compared to other study conditions) may reflect COVID-
19-related CVD (however, numbers were small).46 
Respiratory disease 
Reports from Germany, consistent with our findings, indicate reduced community and hospital presentations 
with acute COPD exacerbations.47 COPD is associated with more severe COVID-19 infection;48 individuals with 
COPD in the UK were recommended to avoid contact with others until September 2020.19,49 Decreased 
emergency department visits for childhood asthma have been reported in the USA, consistent with our 
observations.50 There is no compelling evidence that individuals with asthma are at greater risk of severe 
COVID-19 outcomes, although there was uncertainty at pandemic onset.51–53 Viruses commonly trigger 
asthma exacerbations, so we might have expected to see more asthma contacts. Anecdotally, GPs reported 
increased prescription of asthma therapies around the lockdown period,54 which may explain initial increased 
asthma contacts. Similar increases in COPD exacerbation contacts were not seen around introduction of 
restrictions, despite our definition including prescriptions for oral corticosteroids. One explanation might be 
that, as COPD is a progressive respiratory condition, individuals with COPD may have repeat prescriptions, 
reducing need (compared to those with asthma) to stockpile drugs in a crisis. 
Mental health 
Surveys have reported increased anxiety, depression and self-harm during the pandemic,12,13,55–57 and 
exacerbations of existing OCD, severe mental illness (SMI) and eating disorders have also been reported.58–60 
However, we saw a sustained reduction in primary care contacts for anxiety, depression and other mental 
health conditions consistent with other reports;18 this is concerning as the majority of common mental 
disorders are managed in primary care. Similarly, reduced healthcare contacts for people with SMIs are 
concerning, as people with SMIs are likely to be at greater risk of poor outcomes from COVID-19 due to high 
prevalence of risk factors for adverse outcomes (e.g. CVD, deprivation61–63). 
Alcohol 
Findings from surveys on alcohol consumption in lockdown are mixed, with some reporting increased alcohol 
consumption in up to a third of those surveyed, while others produced differing findings.64 We saw primary 
care contacts for acute alcohol-related events increase before and after restrictions, which is troubling given 
the reduction in contacts for other conditions studied (however, numbers were small). 
Strengths and limitations  
We performed a rapid assessment of changes in primary care contacts following the introduction of UK-
population-wide restrictions up to July 2020 in a large sample respresentative of the UK population. Historical 
data allowed us to compare observed patterns in 2020 to trends in the previous 3-years. We estimated 
relative and absolute changes in contact patterns, with a focus on easy to interpret measures.  
Our study describes and quantifies the reduction in primary care contacts across a wide range of health 
conditions likely to be affected by COVID-19 to generate hypotheses. Further research is needed to 
understand the specific drivers behind these changes. It is important that we understand what happened to 
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individuals who did not consult their GP. Specifically, were they treated in secondary care or did they self-
manage, and how much of our findings can be explained by genuine changes in disease frequency? 
Without hospital and mortality data, we are unable to investigate whether, for example, any reduction in GP 
contacts resulted in corresponding increases in hospital attendances or deaths. We focused on studying any 
record of study conditions, hence, our results reflect all primary care contacts, including diagnoses recorded 
by general practice staff from hospital discharge letters. 
To avoid problems arising from the timing of behaviour change associated with restrictions, our ITS analysis 
excluded a predefined intervention period when individuals’ behaviour was changing dynamically. We took a 
conservative approach and defined our intervention period between 1st March and 28th March 2020 assuming 
that some people would have modified behaviour before the introduction of restrictions. Sensitivity analyses 
varying the start date showed consistent findings. 
Detailed exploration of whether consultation behaviour varied in those considered clinically vulnerable and 
advised to ‘shield18 is beyond the scope of this paper, and any changes in health-seeking behaviour would not 
have reduced the need for care. 
Clinical interpretation  
Given evidence suggesting reduced emergency department attendances and hospital admissions for our study 
conditions, while one explanation could be genuine changes in disease frequency (unlikely, given consistent 
results across disease categories), it is more likely our findings reflect missed opportunities for care. There are 
plausible mechanisms that might explain real reductions in frequency for some of our outcomes. For example: 
1) better glycaemic control in diabetes due to more regular routines when staying home; 2) less respiratory 
disease due to lower exposure to air pollution during lockdown,65 and reduced community-aquired respiratory 
infections due to ‘shielding’ guidelines;19 and 3) reduced alcohol consumption due to pub closure and reduced 
social contact. Conversely, there are plausible mechanisms that could explain genuine increased frequency of 
these conditions (e.g. distress related to the pandemic affecting mental health and alcohol consumption, 
reduced exercise affecting cardiovascular health, changes in diet influencing glycaemic control); and for some 
of our outcomes, e.g., mental health conditions, there is some evidence indicating increased 
frequency.12,13,55,56,58–60 Increases in non-COVID-related excess mortality also make it more likely our observed 
reduction in primary care contacts was due to behavioural changes rather than reduced disease 
frequency.13,66–69 Further, emerging evidence of the systemic complications of COVID-19 infection (particularly 
CVD and diabetes)36,70,71 indicates we might have expected more need for care for these conditions as a direct 
result of the pandemic. 
Implications for policy and research 
Our results are likely to represent a large burden of unmet need, particularly in relation to COPD and mental 
health conditions; healthcare providers should prepare for increases in morbidity and mortality. Further 
research should address whether reduced clinical contact has resulted in excess mortality, and whether we 
need to increase service provision for individuals with increased healthcare needs resulting from delaying 
seeking access to care. While numbers of unstable angina events were small, we note more rapid (compared 
to other study outcomes) return to pre-pandemic consultation rates; this observation needs investigation as it 
may be a direct consequence of the pandemic. Finally, our findings highlight a need to ensure equitable 
access to primary care in future pandemic planning. Countries such as Singapore, which had experienced 
SARS, implemented control measures in primary care rapidly.72 The current pandemic has generated a wealth 
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of experience with alternative ways to access care remotely.73 These lessons must be systematised and 
implemented. 
Conclusions  
We saw substantial reductions in primary care contacts for acute physical and mental health conditions. Our 
findings are likely to represent a considerable burden of unmet need, which may lead to substantial increases 
in subsequent mortality and morbidity.   
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Table 1. Description of denominator populations and condition definitions. 
Condition Denominator population (condition-specific denominator populations) Condition definition 
Diabetes    
Diabetic emergencies All individuals (aged ≥11 years) with prevalent diagnoses of diabetes mellitus at 
the start of each week of follow-up. Individuals contributed to the study 
population from the latest of the start of follow-up in the overall population and 
the date of their first record indicating a diagnosis of diabetes. 
Any record of diabetes-related hyperglycaemia, hypoglycaemia, ketoacidosis, or 
diabetic coma. Multiple records occurring within seven days of each other were 
considered as representing the same event.  
Mental health    
Anxiety All individuals (aged ≥11 years) from the overall study population. 
 
Any record of symptoms or diagnoses of: social phobia, agoraphobia, panic, 
generalized anxiety disorder, and mixed anxiety and depression. Multiple records 
occurring within seven days of each other were considered as representing the 
same event.  
Depression All children (aged 5-17 years) and adults (aged ≥18) from the overall study 
population. 
Any record of major depressive disorder, dysthymia, mixed anxiety and 
depression, and adjustment disorders with depressed mood. We also included 
codes for depressive symptoms. Multiple records occurring within seven days of 
each other were considered as representing the same event. 
Self-harm All children (aged 5-17 years) and adults (aged ≥18 years) from the overall study 
population. 
Self-harm defined as records that indicated explicit or undertermined intention to 
self-harm, non-suicidal or suicidal self-harm (including overdoses with drugs 
commonly implicated in suicide, e.g. paracetamol). Multiple records occurring 
within seven days of each other were considered as representing the same event.  
Serious mental illness All children (aged 5-17 years) and adults (aged ≥18 years) from the overall study 
population. 
Severe mental illness included diagnoses of schizophrenia and other psychotic 
disorders, and bipolar disorders. Multiple records occurring within seven days of 
each other were considered as representing the same event.  
Eating disorders All children (aged 5-17 years) and adults (aged ≥18 years) from the overall study 
population. 
Eating disorders included anorexia nervosa, bulimia nervosa, and other specified 
feeding and eating disorders. Multiple records occurring within seven days of 
each other were considered as representing the same event. 
Obsessive compulsive disorder All children (aged 5-17 years) and adults (aged ≥18 years) from the overall study 
population. 
Obsessive compulsive disorder was defined by codes for body dysmorphic 
disorders, hypochondriasis, hoarding disorder, and body focused repetitive 
behaviour disorders. Multiple records occurring within seven days of each other 
were considered as representing the same event.  
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Condition Denominator population (condition-specific denominator populations) Condition definition 
Respiratory    
Asthma exacerbations All individuals (aged ≥11 years) with a current asthma diagnosis (i.e. asthma code 
in the last two or three years if aged <18 years or 18+ years, respectively). 
Individuals joined the study population from the start of follow-up in the overall 
population if there was a current asthma diagnosis (i.e. within last 2-3 years) at 
this time or from the date of their first record indicating an asthma diagnosis 
within overall follow-up. Participants remained in the study until there was no 
current asthma diagnosis or the end of overall follow-up. They were able to re-
enter the study if there was a later diagnostic code for asthma before the end of 
overall follow-up. Following an existing definition, individuals 40 years and over 
with asthma were considered as likely to have COPD (and therefore not included 
in the asthma study population [denominator]) if they had a subsequent COPD 
diagnosis recorded within the two years following the current asthma record.74 
Asthma exacerbations were defined as records for morbidity codes for asthma 
exacerbations and status asthmaticus, and a primary care prescription for an oral 
corticoseroid.21 Multiple records occurring within 14 days of each other were 
considered as representing the same event. 
 
COPD exacerbations Adults (aged ≥41 years) with an established diagnosis of COPD and evidence of a 
smoking history.75 Individuals joined the study population from the latest of the 
start of follow-up in the overall population and the date of their first record 
indicating diagnosis of COPD. 
Exacerbations of COPD were defined using morbidity codes in individuals with 
existing COPD for COPD exacerbations, lower respiratory tract infections, 
breathlessness or sputum production, and a new prescription for an oral 
corticosteroid or antibiotic.22 Multiple records occurring within 14 days of each 
other were considered as representing the same event. 
Cardiovascular   
Myocardial infarction All adults (aged >31 years) Any record for myocardial infarction allowing for a 1-year window between 
successive records. Multiple records occurring within one year of each other 
were considered as representing the same event. 
Unstable angina All adults (aged ≥31years) 
 
 
Any record for unstable angina, allowing for a 6-month window between 
successive records. Multiple records occurring within six months of each other 
were considered as representing the same event. 
Transient ischaemic attacks All adults (aged ≥31 years) Any record for transient ischaemic, allowing for a 6-month window between 
successive records. Multiple records occurring within six months of each other 
were considered as representing the same events 
Cerebrovascular accident All adults (aged ≥31 years) 
 
Any record for cerebrovascular accidents, allowing for a 1-year window between 
successive records. Multiple records occurring within one year of each other 
were considered as representing the same event. 
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Condition Denominator population (condition-specific denominator populations) Condition definition 
Cardiac failure All adults (aged ≥31 years) 
 
Given the complexity with capturing acute events for a chronic condition, we only 
counted an individual’s first ever diagnosis with cardiac failure. 
Venous thromboembolism 
(pulmonary embolism and deep 
venous thrombosis) 
All adults (aged ≥31 years) Any record for venous thromboembolism, allowing for a 1-year window between 
successive records. Multiple records occurring within one year of each other 
were considered as representing the same event. 
Alcohol    
Acute alcohol-related event All adults (aged ≥18 years)  Any record for acute physical or psychological alcohol-related event, including 
acute alcoholic pancreatitis, Multiple records occurring within 14 days of each 
other were considered as representing the same event. 
74 Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax 2018; 73: 313–20. 
21 Bloom CI, Palmer T, Feary J, Quint JK, Cullinan P. Exacerbation patterns in adults with Asthma in England A population-based study. Am J Respir Crit Care Med 2019; 199: 446–53. 
75 Quint JK, Müllerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open 2014; 4: 1–8. 
22 Rothnie KJ, Müllerová H, Hurst JR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One 2016; 11: 1–14. 
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Table 2. General population denominator population defined in first week of January 2017-2020. All figures are n (%) 
  General population 
 Category 2017  2018  2019  2020  
Overall Overall denominator 9,863,903 (100) 10,124,026 (100) 10,286,472 (100) 10,226,939 (100) 
          
Age (years) 11 - 20 1,233,387 (13) 1,283,296 (13) 1,319,983 (13) 1,325,412 (13) 
 21 - 30 1,455,550 (15) 1,499,066 (15) 1,517,439 (15) 1,505,172 (15) 
 31 - 40 1,559,933 (16) 1,622,838 (16) 1,662,883 (16) 1,661,724 (16) 
 41 - 50 1,577,507 (16) 1,579,296 (16) 1,573,889 (15) 1,550,104 (15) 
 51 - 60 1,520,720 (15) 1,564,290 (16) 1,590,738 (16) 1,580,348 (16) 
 61 - 70 1,165,390 (12) 1,166,078 (12) 1,176,134 (11) 1,164,688 (11) 
 71 - 80 833,570 (9) 881,099 (9) 907,289 (9) 904,486 (9) 
 81 - 90 426,769 (4) 436,646 (4) 445,112 (4) 442,098 (4) 
 91 - 100 91,077 (1) 91,417 (1) 93,005 (1) 92,907 (1) 
          
Ethnicity White 4,814,510 (49) 4,965,265 (49) 5,076,482 (49) 4,996,494 (49) 
 South Asian 425,917 (4) 452,344 (5) 463,579 (5) 479,777 (5) 
 Black 261,552 (3) 273,841 (3) 276,359 (3) 282,515 (3) 
 Other 147,583 (2) 162,963 (2) 177,156 (2) 188,423 (2) 
 Mixed 94,174 (1) 102,384 (1) 109,025 (1) 114,211 (1) 
 Missing 4,120,167 (42) 4,167,229 (41) 4,183,871 (41) 4,165,519 (41) 
          
Sex Female 4,921,693 (50) 5,046,616 (50) 5,126,260 (50) 5,092,370 (50) 
 Male 4,942,210 (50) 5,077,410 (50) 5,160,212 (50) 5,134,569 (50) 
          
Region North East 343,510 (4) 348,039 (3) 353,452 (3) 342,460 (3) 
 North West 1,690,063 (17) 1,723,286 (17) 1,753,263 (17) 1,767,506 (17) 
 Yorkshire and the Humber 371,809 (4) 381,620 (4) 390,222 (4) 359,872 (4) 
 East Midlands 259,468 (3) 268,087 (3) 278,011 (3) 233,006 (2) 
 West Midlands 1,571,832 (16) 1,603,107 (16) 1,602,242 (16) 1,625,072 (16) 
 East of England 464,376 (5) 472,509 (5) 472,546 (5) 433,438 (4) 
 South West 1,185,045 (12) 1,216,271 (12) 1,217,968 (12) 1,204,833 (12) 
 South Central 1,242,192 (13) 1,271,663 (13) 1,289,755 (13) 1,303,108 (13) 
 London 1,842,724 (19) 1,929,942 (19) 1,995,412 (19) 2,027,364 (20) 
 South East Coast 827,239 (8) 842,833 (8) 867,299 (8) 862,929 (8) 
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Table 3. Estimated reduction in estimated number of primary care contacts. 
Estimated number of primary care contacts for acute physical and mental health conditions in a hypothetical non-COVID year compared to the number of contacts estimated 
from our model for 2020 at two weekly time points: 26th April and 28th June 2020. Estimates for the number of contacts are in a hypothetical population of one million people 
but the reference populations are condition specific. For example, the estimated number of contacts for diabetic emergencies is among a population of 1 million people aged 
11 years and older with a diabetes mellitus diagnosis, whereas the estimated number of people with depression contacts among one million individuals from the general 
population aged 5 and over. 
Condition Week 
commencing 
Population (age limit) Without COVID-19 & 
restrictions: 
Estimated number of 
contacts in a population of 
1 million (95% CI) 
With COVID-19 & 
restrictions: 
Estimated number of 
contacts in a population of 
1 million (95% CI) 
Difference between 
the estimated weekly 
contacts and 
estimated number of 
contacts with no 
restrictions* 
Cumulative sum of 
the difference in 
primary care 
contacts since 29th 
March* 
Diabetic emergencies 26-Apr People with diabetes diagnosis (11+) 39 (34 - 44) 14 (10 - 20) <100 <100  
28-Jun People with diabetes diagnosis (11+) 38 (33 - 43) 12 (8 - 19) <100 330  
      
Acute alcohol-related event 26-Apr General population (18+) 13 (11 - 14) 16 (15 - 18) >-10 >-100  
28-Jun General population (18+) 14 (13 - 16) 24 (21 - 26) >-10 >-100  
      
Anxiety 26-Apr General population (11+) 1,816 (1,695 - 1,945) 1,266 (1,148 - 1,396) 550 2,300  
28-Jun General population (11+) 1,943 (1,818 - 2,076) 1,532 (1,383 - 1,696) 411 6,600  
      
Depression 26-Apr General population (11+) 2,451 (2,285 - 2,629) 1,391 (1,241 - 1,558) 1,060 4,440  
28-Jun General population (11+) 2,657 (2,484 - 2,843) 1,857 (1,657 - 2,080) 801 12,800  
      
Eating disorders 26-Apr General population (11+) 44 (41 - 47) 29 (26 - 33) <100 <100  
28-Jun General population (11+) 47 (44 - 51) 35 (31 - 39) <100 184  
      
Obsessive compulsive disorder 26-Apr General population (11+) 29 (27 - 31) 22 (19 - 24) <10 <100  
28-Jun General population (11+) 30 (28 - 33) 25 (23 - 29) <10 <100  
      
Self-harm 26-Apr General population (11+) 217 (190 - 247) 145 (130 - 162) <100 307  
28-Jun General population (11+) 254 (226 - 285) 205 (184 - 228) <100 870  
      
Severe mental illness 26-Apr General population (11+) 184 (173 - 196) 155 (142 - 169) <100 119  
28-Jun General population (11+) 203 (192 - 215) 172 (157 - 189) <100 391  
      
Cerebrovascular accident 26-Apr General population (31+) 88 (83 - 94) 56 (50 - 62) <100 135  
28-Jun General population (31+) 100 (93 - 106) 73 (65 - 81) <100 400  
      
Transient ischaemic attack 26-Apr General population (31+) 37 (35 - 40) 26 (24 - 29) <100 <100 
 28-Jun General population (31+) 40 (38 - 43) 31 (28 - 35) <10 136 
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Population (age limit) Without COVID-19 & 
restrictions: 
Estimated number of 
contacts in a population of 
1 million (95% CI) 
With COVID-19 & 
restrictions: 
Estimated number of 
contacts in a population of 
1 million (95% CI) 
Difference between 
the estimated weekly 
contacts and 
estimated number of 
contacts with no 
restrictions* 
Cumulative sum of 
the difference in 
primary care 
contacts since 29th 
March* 
       
Heart failure 26-Apr General population (31+) 279 (264 - 295) 181 (167 - 196) <100 408  
28-Jun General population (31+) 308 (292 - 324) 223 (205 - 242) <100 1,240 
       
Myocardial infarction 26-Apr General population (31+) 45 (42 - 47) 35 (33 - 38) <10 <100  
28-Jun General population (31+) 47 (44 - 49) 37 (34 - 41) <10 123  
      
Unstable angina 26-Apr General population (31+) 5 (5 - 6) 4 (4 - 5) <10 <10  
28-Jun General population (31+) 6 (5 - 6) 6 (5 - 7) <10 <10  
      
Venous thromboembolism 26-Apr General population (31+) 67 (63 - 70) 64 (59 - 68) <10 <10  
28-Jun General population (31+) 72 (69 - 76) 63 (58 - 68) <10 <100  
      
Asthma exacerbations 26-Apr People with asthma diagnosis (11+) 4,636 (4,361 - 4,928) 3,617 (3,320 - 3,941) 1,020 3,780  
28-Jun People with asthma diagnosis (11+) 4,254 (3,995 - 4,529) 2,941 (2,643 - 3,273) 1,310 14,100  
      
COPD exacerbations 26-Apr People with COPD diagnosis (41+) 7,863 (7,365 - 8,395) 4,222 (3,768 - 4,730) 3,640 14,400  
28-Jun People with COPD diagnosis (41+) 6,594 (6,147 - 7,073) 3,367 (2,919 - 3,884) 3,230 43,900 
* Estimates of the difference between scenarios and cumulative difference have been rounded to 3 significant digits to avoid overly precise estimates. We did not intend to estimate the exact number of 
“missed” consultations but obtained an estimate of the absolute indirect effect of COVID-19 on different conditions. If the expected difference was <100 or <10 then estimates have been censored for the same 
reason.  
Abbreviations: CI: confidence interval. COPD: chronic obstructive pulmonary disease 
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Figure 1 – Percentage of study populations with contacts for all conditions in 2017-2019 and 2020. 
Percentage of eligible population with contacts for each health condition studied in 2020 compared to 
historical average for that week. Black line, weekly historical average percentage of eligible population 
consulting (2017-2019, grey lines show the data for 2017, 2018, and 2019). Red dashed line, weekly 
percentage of eligible percentage consulting in 2020. Red region shows difference with historical average. Red 
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Figure 2 – Percentage of the study populations with contacts by age group. 
Percentage of the study populations with GP contacts for study conditions over 2020, by age group. Boxplots, 
historical average percentage of study population with GP contacts for the condition of interest. Coloured 
lines, weekly percentage of eligible population with primary care contacts for the condition of interest in 
2020. Red dotted line, introduction of restrictions in UK on March 23rd. Note that cell counts with fewer than 
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Figure 3 – Interrupted time series  
An interrupted time series analysis of the change in GP contacts before and after introduction of UK-wide restrictions. 
A; grey line, the percentage of the study population with primary care contacts for each health condition. Blue region, 
predicted percentage of contacts from the full ITS model. Black vertical lines, data excluded data from the analysis 
from 1st March to 29th March (adjustment-to-restrictions period). B; 95% CI for the estimated relative reduction in the 
percentage of contacts for each health condition immediately after the adjustment-to-restrictions period (29th March 
2020)  compared to the pre-restriction period (OR closer to 0 shows a greater reduction in the estimated percentage 
of people with GP contacts). C; estimated effect of time (in weekly increments) post-restriction introduction on the 
percentage of contacts for each condition. (OR greater that 1 indicates increasing percentage of population with 
contacts over time). Results for 2020 only are shown here (Figure S13 for full model fit to data from 2017) (full relative 
reduction/recovery estimates [95% CIs] Tables S6 and S7). 
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